我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的隐私政策。
相关临床试验
0
0 进行中
药物批准
批准总数
监管机构
监管机构数
成立时间
N/A
暂无试验阶段数据
暂无试验数据
暂无批准数据
- Sycamore Partners has completed its acquisition of Walgreens Boots Alliance, taking the pharmacy giant private in partnership with Stefano Pessina and his family. - WBA shareholders received $11.45 per share in cash consideration, with potential for an additional $3.00 per share from future VillageMD monetization proceeds. - Following the transaction closure, Walgreens, Boots Group, Shields Health Solutions, CareCentrix and VillageMD will operate as separate standalone companies under private ownership. - The acquisition removes WBA from Nasdaq trading and marks a new chapter for the global pharmacy and healthcare services conglomerate.